SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-05-009282
Filing Date
2005-08-02
Accepted
2005-08-02 16:16:36
Documents
7
Period of Report
2005-07-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS, INC. y11403e8vk.txt 8-K 6858
2 PRESS RELEASE y11403exv99w1.txt EX-99.1 32479
3 PRESS RELEASE y11403exv99w2.txt EX-99.2 11528
4 PRESS RELEASE y11403exv99w3.txt EX-99.3 8920
5 PRESS RELEASE y11403exv99w4.txt EX-99.4 8650
6 PRESS RELEASE y11403exv99w5.txt EX-99.5 5539
7 TEXTUAL REPRESENTATION OF CERTAIN PORTIONS OF THE WEBCAST CONFERENCE CALL HELD O y11403exv99w6.txt EX-99.6 21400
  Complete submission text file 0000950123-05-009282.txt   97070
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 05992255
SIC: 2835 In Vitro & In Vivo Diagnostic Substances